Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 May;62(5):1533-8.
doi: 10.1002/art.27379.

Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis

Affiliations

Association of normal nailfold end row loop numbers with a shorter duration of untreated disease in children with juvenile dermatomyositis

Rochella A Ostrowski et al. Arthritis Rheum. 2010 May.

Abstract

Objective: To determine the association of normal numbers of end row loops (ERLs) in nailfold capillaries at the time of diagnosis of juvenile dermatomyositis (DM) with clinical findings in untreated children with the disease and to identify predictors of the development of decreased numbers of ERLs.

Methods: Clinical and laboratory data from 80 untreated children with juvenile DM were collected. ERL numbers were recorded at the time of diagnosis and at 24 months and 36 months thereafter. The 12 children who had normal ERLs at diagnosis were compared with the remaining 68 children. Outcomes included the duration of untreated disease, the duration of treatment with immunosuppressive medications, family medical history, Disease Activity Score (DAS) for juvenile DM, creatinine phosphokinase level, aldolase level, absolute number of CD3-CD56+/16+ natural killer cells, and von Willebrand factor antigen level. Cross-sectional and longitudinal analyses were performed.

Results: At diagnosis, children with normal ERLs had a shorter duration of untreated disease (P = 0.03) and a lower skin DAS (P = 0.045). Over time, an increased likelihood of having decreased numbers of ERLs was associated with a longer duration of untreated disease and with a higher skin DAS.

Conclusion: The presence of a normal number of ERLs in juvenile DM appears to be associated with a shorter duration of symptoms and may be a useful indicator of disease chronicity in the newly diagnosed child. Normal ERLs is also associated with a lower skin DAS. The lack of association between normal ERLs and other variables indicates that normal findings on nailfold capillaroscopy should not be used as justification to delay immunosuppressive therapy in children with typical symptoms of juvenile DM.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Sequential studies at diagnosis, 24, and 36 months of the number of End Row Loops (ERL).

Similar articles

Cited by

References

    1. Pachman LM, Abbott K, Sinacore JM, Amoruso L, Dyer A, Lipton R, et al. Duration of illness is an important variable for untreated children with juvenile dermatomyositis. J Pediatrics. 2006;148:247–53. - PubMed
    1. Pachman LM, Lipton R, Ramsey-Goldman R, Shamiyeh E, Abbott K, Mendez EP, et al. History of infection before the onset of juvenile dermatomyositis: Results from the national institute of arthritis and musculoskeletal and skin diseases research registry. Arthritis Rheum. 2005;15:166–72. - PubMed
    1. Lutz J, Huwiler KG, Fedczyna T, Lechman TS, Crawford S, Kinsella TR, et al. Increased plasma thrombospondin-1 (TSP-1) levels are associated with the TNF alpha-308A allele in children with juvenile dermatomyositis. Clinical Immunol. 2002;103:260–3. - PubMed
    1. Pachman LM, Liotta-Davis M, Hong D, Kinsella TR, Mendez E, Kinder J, Chen EH. TNFα-308A allele in juvenile dermatomyositis-association with increased TNFα production, disease duration, and pathological calcifications. Arthritis Rheum. 2000;43:2368–2377. - PubMed
    1. Feldman BM, Reed AM, Rider LG, Pachman LM. Juvenile dermatomyositis & other idiopathic inflammatory myopathies of childhood. Lancet. 2008;371:2201–2212. - PubMed

Publication types

Substances